You are here:

Risperidone (Risperdal®)


Following a full submission.

Risperidone is accepted for use within NHS Scotland for the treatment of episodes of mania in bipolar disorder.

Risperidone has similar efficacy to haloperidol in improving symptom scores, with fewer extrapyramidal side effects. In an economic model based on indirect comparison, monotherapy with risperidone appears to be cost-effective. No evidence is submitted on its cost-effectiveness profile in co-therapy.

Drug Details

Drug Name: Risperidone (Risperdal®)
SMC Drug ID: 113/04
Manufacturer: Janssen-Cilag Ltd
Indication: Mania in bipolar disorder
BNF Category:
Sub Category: 4.2 Drugs used in psychoses and related disorders
Submission Type: Full submission
Status: Accepted
Date Advice Published: 9 August 2004